8 completed. 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
| Phase 1 | 2 | Completed 2 |
Follow Oxagen Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proof of Concept Study of OC000459 in Eosinophilic Esophagitis OC000459, Placebo - Eosinophilic Esophagitis | Phase 2 | Completed | Oxagen Ltd | 26 | 2010-08-01 | 2012-01-05 |
| Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4 OC000459 - Healthy Volunteers | Phase 1 | Completed | Oxagen Ltd | 20 | 2010-02-01 | 2010-09-02 |
| OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma OC000459 or placebo - Mild to Moderate Persistent Asthma | Phase 2 | Completed | Oxagen Ltd | 480 | 2009-04-01 | 2010-09-02 |
| OC000459 Dose Finding Study in Hay Fever Sufferers. OC000459, Placebo - Allergic Rhinitis | Phase 2 | Completed | Oxagen Ltd | 120 | 2008-05-01 | 2009-02-24 |
| A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis OC000459, Placebo - Allergic Rhinitis | Phase 2 | Completed | Oxagen Ltd | 36 | 2007-03-01 | 2011-10-07 |
| Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects OC000459, Placebo - Asthma | Phase 2 | Completed | Oxagen Ltd | 132 | 2007-01-01 | 2010-01-28 |
| OC000459 Bronchial Allergen Challenge OC000459, Placebo - Bronchial Asthma | Phase 2 | Completed | Oxagen Ltd | 20 | 2006-02-01 | 2010-01-26 |
| The Effects of OC000459 on Nasal Mediators Oxagen OC000459 - Allergic Rhinitis | Phase 1 / Phase 2 | Completed | Trevor Hansel | 12 | 2023-10-30 |
Asthma (3) · Rhinitis, Allergic (3) · Eosinophilic Esophagitis (1)
(5-fluoro-2-methyl-3-quinolin-2-ylmethylindo-1-yl)acetic acid (7)
United Kingdom (3) · Austria (2) · Russia (2) · Bulgaria (1) · Hungary (1) · Poland (1) · Romania (1) · Switzerland (1) · Ukraine (1)
Alex Straumann, Dr (1) · David Singh, MD (1) · Friedrich Horak, Prof Dr (1) · Salvatore Febbraro, Dr (1) · Trevor T Hansel, FRCPath (1)